BLOPRESS Tablet Ref.[49812] Active ingredients: Candesartan

Source: Health Products Regulatory Authority (IE)  Revision Year: 2021  Publisher: CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany

Product name and form

Blopress 2 mg Tablets.

Pharmaceutical Form

Tablet.

Blopress 2 mg Tablets are round white tablets.

Qualitative and quantitative composition

Each tablet contains 2 mg candesartan cilexetil.

Each tablet contains 95.4 mg lactose monohydrate.

For a full list of excipients, see section 6.1.

Active Ingredient Description
Candesartan

Candesartan is an AIIRA, selective for AT1 receptors, with tight binding to and slow dissociation from the receptor. It has no agonist activity. The antagonism of the angiotensin II (AT1) receptors results in dose related increases in plasma renin levels, angiotensin I and angiotensin II levels, and a decrease in plasma aldosterone concentration.
List of Excipients

Carmellose calcium
Hydroxypropylcellulose
Lactose monohydrate
Magnesium stearate
Maize starch
Macrogol

Pack sizes and marketing

Polypropylene blister.

Blister packs of 7, 14 and 28 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

CHEPLAPHARM Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany

Marketing authorization dates and numbers

PA2239/014/001

Date of first authorisation: 14th November 1997
Date of last renewal: 28th April 2007

Drugs

Drug Countries
BLOPRESS Austria, Brazil, Germany, Ecuador, Spain, Hong Kong, Ireland, Italy, Japan, Tunisia
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈